Kaitai Capital is a professional investment management organization.
KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 29, 2022
Rgenta Therapeutics
|
Series A | $52M | Biotechnology | — |
Sep 26, 2022
Realibox
|
Series A | ¥100M | 3D Technology | — |
Dec 9, 2021
Zhiyan Technology
|
Series B | ¥100M | Analytics | — |
Jul 27, 2021
Hongyun Biotech
|
Series B | ¥100M | Biotechnology | — |
May 25, 2021
Rgenta Therapeutics
|
Seed | $18M | Biotechnology | — |